• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国 1991 年至 2006 年期间癌前和恶性皮肤病变发病率的变化趋势。

Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006.

机构信息

Department of Dermatology, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

J Korean Med Sci. 2010 Jun;25(6):924-9. doi: 10.3346/jkms.2010.25.6.924. Epub 2010 May 24.

DOI:10.3346/jkms.2010.25.6.924
PMID:20514316
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2877235/
Abstract

We evaluated the recent trend in the incidence of premalignant and malignant skin lesions between 1991 and 2006. Among 571,057 newly registered dermatology out-patients from our 8 affiliated university hospitals, 2,598 were diagnosed with a premalignant (899, 0.16%) or malignant skin lesions (1,699, 0.30%). Of 899 premalignant cases, 71.2% were actinic keratosis (AK), and 24.6% were Bowen's disease. Of 1,699 malignant cases, 46.2% were basal cell carcinoma, followed by squamous cell carcinoma (19.1%) and melanoma (7.1%). This 16-yr survey was divided equally into two time periods to compare the incidence of premalignant and malignant skin lesions at different time settings. Between 1991 and 1998, the incidence of cutaneous premalignancy was 0.10% which doubled during 1999-2006. For cutaneous malignancy, the incidence was 0.25% during 1991-1998 and 0.34% in 1999-2006. Incidence of AK among the new outpatients was 0.07% in 1991-1998 which staggered up to 0.15% in 1999-2006. These findings show an increase of both premalignant and malignant skin lesions, AK in particular in the dermatology outpatient-based incidence.

摘要

我们评估了 1991 年至 2006 年间癌前和恶性皮肤病变的发病率变化趋势。在我们 8 所附属医院的 571,057 名新登记的皮肤科门诊患者中,有 2,598 名被诊断患有癌前病变(899 例,0.16%)或恶性皮肤病变(1,699 例,0.30%)。在 899 例癌前病变中,71.2%为光化性角化病(AK),24.6%为 Bowen 病。在 1,699 例恶性病例中,46.2%为基底细胞癌,其次为鳞状细胞癌(19.1%)和黑色素瘤(7.1%)。这项 16 年的调查分为两个相等的时间段,以比较不同时间设置下癌前和恶性皮肤病变的发病率。1991 年至 1998 年期间,皮肤癌前病变的发病率为 0.10%,而在 1999 年至 2006 年期间则翻了一番。对于皮肤恶性肿瘤,1991 年至 1998 年的发病率为 0.25%,1999 年至 2006 年的发病率为 0.34%。1991 年至 1998 年期间,新门诊患者中 AK 的发病率为 0.07%,而在 1999 年至 2006 年期间则上升至 0.15%。这些发现表明,癌前和恶性皮肤病变,尤其是皮肤科门诊患者中的 AK 发病率都有所增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/54701e686a06/jkms-25-924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/e164a8920238/jkms-25-924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/021375ba9c1c/jkms-25-924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/54701e686a06/jkms-25-924-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/e164a8920238/jkms-25-924-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/021375ba9c1c/jkms-25-924-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb8/2877235/54701e686a06/jkms-25-924-g007.jpg

相似文献

1
Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006.韩国 1991 年至 2006 年期间癌前和恶性皮肤病变发病率的变化趋势。
J Korean Med Sci. 2010 Jun;25(6):924-9. doi: 10.3346/jkms.2010.25.6.924. Epub 2010 May 24.
2
Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.皮肤鳞状细胞癌患者的癌前病变、基底细胞癌和黑色素瘤。
Arch Dermatol Res. 2021 Dec;313(10):879-884. doi: 10.1007/s00403-020-02114-w. Epub 2020 Aug 9.
3
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation.肾移植和心脏移植后发生的皮肤上皮癌前病变和恶性病变的比较流行病学研究。
J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):222-9. doi: 10.1016/0190-9622(95)90239-2.
4
The occurrence of non-melanoma malignant skin lesions and non-cutaneous squamous-cell carcinoma among metastatic melanoma patients: an observational cohort study in Denmark.转移性黑色素瘤患者中非黑色素瘤恶性皮肤病变和非皮肤鳞状细胞癌的发生情况:丹麦的一项观察性队列研究
BMC Cancer. 2016 May 3;16:295. doi: 10.1186/s12885-016-2315-0.
5
[Not Available].[无可用内容]
Praxis (Bern 1994). 2016 Sep;105(18):1071-7. doi: 10.1024/1661-8157/a002459.
6
Results of second-stage screening for skin cancers in Oita Prefecture, Japan.日本大分县皮肤癌二期筛查结果。
J Dermatol. 2015 Dec;42(12):1160-4. doi: 10.1111/1346-8138.13016. Epub 2015 Jul 16.
7
[Increasing number of skin cancer cases--also among the younger].皮肤癌病例数量不断增加——年轻人中也是如此。
Lakartidningen. 2005;102(26-27):1972-5.
8
Cutaneous complications in heart transplant recipients in Norway 1983-1993.1983年至1993年挪威心脏移植受者的皮肤并发症
Acta Derm Venereol. 1995 Sep;75(5):400-3. doi: 10.2340/0001555575400403.
9
Actinic keratoses in subjects from la Mitad del Mundo, Ecuador.来自厄瓜多尔基多世界中心地区人群的光化性角化病。
BMC Dermatol. 2020 Oct 27;20(1):11. doi: 10.1186/s12895-020-00109-8.
10
Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.光化性角化病面积和严重指数(AKASI)与鳞状细胞癌的发生率相关。
J Eur Acad Dermatol Venereol. 2018 May;32(5):752-756. doi: 10.1111/jdv.14682. Epub 2017 Dec 18.

引用本文的文献

1
Prevalence of head and face actinic keratosis among older community residents aged ≥60 years in Shanghai: a cross-sectional study.上海≥60岁老年社区居民头面部光化性角化病患病率:一项横断面研究。
Front Med (Lausanne). 2025 Aug 11;12:1558683. doi: 10.3389/fmed.2025.1558683. eCollection 2025.
2
A study on the global burden of non-melanoma skin cancer from 1990 to 2019.一项关于1990年至2019年非黑色素瘤皮肤癌全球负担的研究。
Arch Med Sci. 2024 Apr 14;20(6):1902-1908. doi: 10.5114/aoms/187003. eCollection 2024.
3
Risk of Skin Cancer and Actinic Keratosis in Patients with Rosacea: A Nationwide Population-based Cohort Study.

本文引用的文献

1
Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update.日本恶性黑色素瘤及其他皮肤癌的统计概况:2007年更新版
Int J Clin Oncol. 2008 Feb;13(1):33-41. doi: 10.1007/s10147-007-0751-1. Epub 2008 Feb 29.
2
Predictions of skin cancer incidence in the Netherlands up to 2015.对荷兰截至2015年皮肤癌发病率的预测。
Br J Dermatol. 2005 Mar;152(3):481-8. doi: 10.1111/j.1365-2133.2005.06386.x.
3
Nonmelanoma skin cancer in the Federal State of Saarland, Germany, 1995-1999.1995 - 1999年德国萨尔州的非黑色素瘤皮肤癌
玫瑰痤疮患者皮肤癌和光化性角化病的发病风险:一项全国范围内基于人群的队列研究。
Acta Derm Venereol. 2022 Oct 27;102:adv00803. doi: 10.2340/actadv.v102.2563.
4
Analysis on the Effectiveness and Characteristics of Treatment Modalities for Bowen's Disease: An Observational Study.鲍温病治疗方式的有效性和特征分析:一项观察性研究
J Clin Med. 2022 May 12;11(10):2741. doi: 10.3390/jcm11102741.
5
Incidence and Prevalence of Skin Cancers in South Korea from 2008 to 2016: A Nation-Wide Population Based Study.2008年至2016年韩国皮肤癌的发病率和患病率:一项基于全国人口的研究。
Ann Dermatol. 2022 Apr;34(2):105-109. doi: 10.5021/ad.2022.34.2.105. Epub 2022 Mar 24.
6
Analysis of Judicial Precedents Cases Regarding Skin Cancer from 1997 to 2017 in Republic of Korea.1997年至2017年韩国皮肤癌司法判例案件分析。
Ann Dermatol. 2019 Jun;31(3):300-306. doi: 10.5021/ad.2019.31.3.300. Epub 2019 May 1.
7
A retrospective study of changes in skin cancer characteristics over 11 years.一项关于11年间皮肤癌特征变化的回顾性研究。
Arch Craniofac Surg. 2020 Apr;21(2):87-91. doi: 10.7181/acfs.2020.00024. Epub 2020 Apr 20.
8
Effectiveness of radiotherapy for head and neck skin cancers: a single-institution study.头颈部皮肤癌放疗的有效性:一项单机构研究。
Radiat Oncol J. 2019 Dec;37(4):293-301. doi: 10.3857/roj.2019.00381. Epub 2019 Dec 31.
9
A Retrospective Clinical View of Basal Cell Carcinoma and Squamous Cell Carcinoma in the Head and Neck Region: A Single Institution's Experience of 247 Cases over 19 Years.头颈部基底细胞癌和鳞状细胞癌的回顾性临床观察:一家机构19年247例病例的经验
Arch Craniofac Surg. 2016 Jun;17(2):56-62. doi: 10.7181/acfs.2016.17.2.56. Epub 2016 Jun 21.
10
Clinical Features of Cutaneous Premalignant Lesions in Busan City and the Eastern Gyeongnam Province, Korea: A Retrospective Review of 1,292 Cases over 19 Years (1995~2013).韩国釜山及庆南东部地区皮肤癌前病变的临床特征:对1995年至2013年19年间1292例病例的回顾性研究
Ann Dermatol. 2016 Apr;28(2):172-8. doi: 10.5021/ad.2016.28.2.172. Epub 2016 Mar 31.
Br J Cancer. 2003 Oct 6;89(7):1205-8. doi: 10.1038/sj.bjc.6601294.
4
The epidemiology of skin cancer.皮肤癌的流行病学
Br J Dermatol. 2002 Apr;146 Suppl 61:1-6. doi: 10.1046/j.1365-2133.146.s61.2.x.